Some health experts warn against microdosing weight loss drugs

Demand for weight-loss drugs, such as Ozempic and Wegovy, has soared in recent years despite the high cost and unpleasant side effects for some people. The New York Times reports that some patients are finding a way around both of these concerns by experimenting with microdosing the drugs. Dr. Jeremy Faust, an emergency physician at Brigham and Women’s Hospital in Boston, joins CBS News to assess the safety and risks of the practice.